-
Explore the Potential of Innovative MICE Concepts at Pullman Danang Beach Resort
July 29, 2025 -
CreateAI, a Leader in Applied AI Technology, Launches Animon.ai Studio Version for Creators to Make Their Own Anime Series
July 29, 2025 -
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025: U.S. POINTER STUDY SHOWS STRUCTURED LIFESTYLE PROGRAM TARGETING MULTIPLE RISK FACTORS IMPROVES COGNITION IN OLDER ADULTS AT RISK OF COGNITIVE DECLINE
July 29, 2025 -
Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer's Association International Conference (AAIC)
July 28, 2025 -
Antengene Announces XPOVIO® Approved in China for the Second-Line Treatment of Multiple Myeloma, Marking the Third Approved Indication of the Drug
July 28, 2025 -
Interventional Robot's RCT Research Published in JNIS, a Leading Journal in Neurointervention!
July 28, 2025 -
DIFC's H1 2025 results fuel Dubai's economic vision (D33) and demonstrate global leadership in financial services and innovation
July 28, 2025 -
Carlsberg Asia Unites Football Fans in a Legendary Celebration of Liverpool FC
July 28, 2025 -
Doosan Robotics Accelerates Push to Become an AI Robot Solutions Leader
July 28, 2025 -
FNZ Announces Strategic Partnership with Microsoft to Accelerate the Transformation of the Wealth Management Industry
July 28, 2025 -
The 2025 China-ASEAN Education Cooperation Week Held in Guizhou
July 28, 2025 -
Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, 'EYLUXVI® (ALT-L9)'
July 28, 2025 -
Infobip named a Leader in 2025 Gartner® Magic Quadrant™ for Communications Platform-as-a-Service for the third consecutive year
July 28, 2025 -
Antengene Announces XPOVIO® Approved in China for the Second-Line Treatment of Multiple Myeloma, Marking the Third Approved Indication of the Drug
July 28, 2025 -
Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025
July 28, 2025